Zoetis | ZTS - Des Atouts





Des Atouts Changement Date
AbbVie USD 135.12B 1.35B 2026-06
Align Technology USD 6.42B 103.41M 2026-06
Bayer EUR 107.29B 659M 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Charles River Laboratories USD 7.53B 198.16M 2026-06
Coherus Biosciences USD 191.18M 74.84M 2026-06
Dentsply International USD 5.2B 25M 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Henry Schein USD 11.38B 77M 2026-06
Idexx Laboratories USD 3.44B 56.84M 2026-06
Illumina USD 6.65B 91M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
J&J USD 201.06B 167M 2026-06
Laboratory Of America USD 18.53B 554.8M 2026-06
Merck USD 129.8B 1.12B 2026-06
Neogen USD 3.35B 13M 2026-03
Pacira USD 1.24B 35.44M 2026-06
Perrigo USD 7.61B 373.8M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Phibro Animal Health USD 1.5B 56.12M 2026-06
Quest Diagnostics USD 16.94B 266M 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Sanofi EUR 128.02B 1.22B 2026-03
Zoetis USD 15.08B 77M 2026-06